HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?

Bioessays. 2019 Jan;41(1):e1800128. doi: 10.1002/bies.201800128. Epub 2018 Dec 10.

Abstract

Despite abundant evidence associating CD38 overexpression and CD4 T cell depletion in HIV infection, no causal relation has been investigated. To address this issue, a series of mechanisms are proposed, supported by evidence from different fields, by which CD38 overexpression can facilitate CD4 T cell depletion in HIV infection. According to this model, increased catalytic activity of CD38 may reduce CD4 T cells' cytoplasmic nicotin-amide adenine dinucleotide (NAD), leading to a chronic Warburg effect. This will reduce mitochondrial function. Simultaneously, CD38's catalytic products ADPR and cADPR may be transported to the cytoplasm, where they can activate calcium channels and increase cytoplasmic Ca2+ concentrations, further altering mitochondrial integrity. These mechanisms will decrease the viability and regenerative capacity of CD4 T cells. These hypotheses can be tested experimentally, and might reveal novel therapeutic targets. Also see the video abstract here https://youtu.be/k1LTyiTKPKs.

Keywords: CD38; CD4-Positive T lymphocytes; HIV/AIDS; NAD; Warburg effect; immune activation; immunometabolism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ADP-ribosyl Cyclase 1 / genetics*
  • ADP-ribosyl Cyclase 1 / metabolism
  • Disease Progression
  • Gene Expression Regulation*
  • HIV Infections / enzymology*
  • HIV Infections / genetics
  • Humans
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / metabolism
  • Up-Regulation

Substances

  • Membrane Glycoproteins
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1